Status:

COMPLETED

Retrospective, Non-interventional Clinical Investigation of the Safety and Performance of 640AD Monofocal Intraocular Lens

Lead Sponsor:

Medicontur Medical Engineering Ltd

Conditions:

Cataract

Pseudophakia

Eligibility:

All Genders

18+ years

Brief Summary

Medicontur hydrophilic posterior chamber monofocal intraocular lens (IOL) is indicated to improve vision at far distance in adults with cataract and/or ametropia (hyperopia, myopia), secondarily to re...

Eligibility Criteria

Inclusion

  • Adult males or females above 18 years of age;
  • Pseudophakic patients implanted with 640AD monofocal IOLs (implanted between December 2021 - December 2022);
  • Diagnosis of cataract and/or ametropia (hyperopia, myopia);
  • Subject who has signed an informed consent form.
  • Patients who have participated in all visits that are subject to retrospective data collection.

Exclusion

  • Patients who are not targeted to emmetropia ( outside -0,5 and 0,5 D)
  • Patients with the following condition(s) at the time of the baseline visit:
  • Corneal astigmatism \> 1.5 D
  • Uncontrolled diabetic retinopathy
  • Iris neovascularization
  • Congenital eye abnormality
  • Uncontrolled glaucoma
  • Pseudoexfoliation syndrome
  • Amblyopia
  • Uveitis
  • AMD (advanced AMD)
  • Retinal detachment
  • Prior ocular surgery in personal medical history
  • Previous laser treatment
  • Corneal diseases
  • Severe retinal diseases (dystrophy, degeneration)
  • High myopia
  • Inadequate visualization of the fundus on preoperative examination
  • Patients deemed by the clinical investigator because of any systemic disease
  • Pregnancy
  • Eye trauma in medical history
  • Current use of systemic steroids or topical ocular medication
  • Patients with any eye condition that could affect vision in the opinion of the investigator at the time of the 12-month follow-up: (corneal ectasia, retinal diseases, glaucoma, uveitis, dry eye or amblyopia, etc.)

Key Trial Info

Start Date :

May 23 2023

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 25 2024

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06578910

Start Date

May 23 2023

End Date

April 25 2024

Last Update

August 30 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

SZTE ÁOK Szent-Györgyi Albert Klinikai Központ Szemészeti Klinika

Szeged, Hungary, 6720